Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-18 · accession 0001926254-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-18 | FENC | Hackman Jeffrey S. | CEO, Dir | M - OptEx | $0.00 | +13.7K | 28.7K | +91% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-02-18 | M | A | 13,710 | $0.00 | 28,710 | D | — | — | (F1) Represents settlement of PSUs that vested on February 18, 2026. |